Genetically proxied inhibition of L-2-hydroxyglutarate dehydrogenase and the risk of coronary artery disease: A Mendelian randomization study
View ORCID ProfileEuijun Song
doi: https://doi.org/10.1101/2023.01.15.23284550
Euijun Song
1Yonsei University College of Medicine, Seoul, Republic of Korea
M.D.Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted February 09, 2023.
Genetically proxied inhibition of L-2-hydroxyglutarate dehydrogenase and the risk of coronary artery disease: A Mendelian randomization study
Euijun Song
medRxiv 2023.01.15.23284550; doi: https://doi.org/10.1101/2023.01.15.23284550
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2964)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12774)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4605)
- Geriatric Medicine (422)
- Health Economics (732)
- Health Informatics (2938)
- Health Policy (1070)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4385)
- Nursing (237)
- Nutrition (642)
- Oncology (2282)
- Ophthalmology (649)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (499)
- Public and Global Health (6973)
- Radiology and Imaging (1538)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)